Hepatitis C Articles (HCV)
Back
	An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients       This study is currently recruiting participants. Verified October 2012 by Vertex Pharmaceuticals Incorporated   http://clinicaltrials.gov/ct2/show/NCT01467505?term=hcv+liver+transplant&rank=40           View Older Articles   Back to Top   www.natap.org